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Abstract 
Background: Health and medical research funding agencies are increasingly interested in measuring the impact of 
funded research. We present a research impact case study for the first four years of an Australian National Health and 
Medical Research Council funded Centre of Research Excellence in Cardiovascular Outcomes Improvement (2016–
2020). The primary aim of this paper was to explore the application of a research impact matrix to assess the impact of 
cardiovascular outcomes improvement research.
Methods: We applied a research impact matrix developed from a systematic review of existing methodological 
frameworks used to measure research impact. This impact matrix was used as a bespoke tool to identify and under-
stand various research impacts over different time frames. Data sources included a review of existing internal docu-
mentation from the research centre and publicly available information sources, informal iterative discussions with 10 
centre investigators, and confirmation of information from centre grant and scholarship recipients.
Results: By July 2019, the impact on the short-term research domain category included over 41 direct publications, 
which were cited over 87 times (median journal impact factor of 2.84). There were over 61 conference presentations, 
seven PhD candidacies, five new academic collaborations, and six new database linkages conducted. The impact on 
the mid-term research domain category involved contributions towards the development of a national cardiac regis-
try, cardiovascular guidelines, application for a Medicare Benefits Schedule reimbursement item number, introduction 
of patient-reported outcome measures into several databases, and the establishment of nine new industry collabora-
tions. Evidence of long-term impacts were described as the development and use of contemporary management 
for aortic stenosis, a cardiovascular risk prediction model and prevention targets in several data registries, and the 
establishment of cost-effectiveness for stenting compared to surgery.
Conclusions: We considered the research impact matrix a feasible tool to identify evidence of academic and policy 
impact in the short- to midterm; however, we experienced challenges in capturing long-term impacts. Cost contain-
ment and broader economic impacts represented another difficult area of impact to measure.
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Background
Health and medical research funding agencies are 
increasingly interested in measuring return on invest-
ment through improved health outcomes. This focus 
reflects the ultimate goal of research to generate new 
knowledge that can be applied to improve health and 
reduce the burden of illness. Historical investment in 
health research has not always translated into healthcare 
policy and practice [1–3], leading to an equivocal use of 
scarce resources in both the generation of research and 
functioning of health systems [4, 5]. Consequently, meas-
uring the impact of research including and beyond aca-
demic outputs, such as peer-reviewed journal articles, 
is crucial [6–9]. However, there is a paucity of evidence 
suggesting an increase in the number of health research 
projects that measure impact, particularly beyond aca-
demic criteria [10].
Measuring the impact of health research is an evolv-
ing and contested activity. The pathway of research 
impact is often conceptualized and represented as a sim-
ple linear process (Fig.  1). However, impacts are rarely 
manifested through linear pathways in complex systems 
such as healthcare [11]. This leaves the rigidity of many 
frameworks for measuring research impact as potentially 
unfit for this purpose, if they misrepresent the complex 
research—practice ecosystem. The focus of research 
policy has also shifted over the years from research 
utilization to knowledge mobilization [12]. Early tools 
for the assessment of impact almost solely captured aca-
demic productivity, rather than broader impacts to soci-
ety [13]. In recent years, research impact is increasingly 
conceptualized in terms of promoting national prosper-
ity, as the focus of research policy has turned toward 
impacts on the economy, society, environment, and cul-
ture; for example, the introduction of a “National Inter-
est Test” in 2018 for Australian research grants allows 
the Commonwealth Minister for Education veto power 
to reject applications recommended for funding by the 
Australian Research Council [14]. Given the conceptual 
ambiguity of “research impact”, it can be difficult for aca-
demics to articulate the patterns and pathways by which 
transformation of their research into “impact” occurs.
There are numerous ways to define research impact 
[16]. The International School on Research Impact 
Assessment, which was set up to facilitate the application 
of robust and repeatable evaluation methods for research 
impact, recommends analysis of the research con-
text prior to conducting a research impact assessment. 
This paper centres on a case study for the evaluation of 
research impact in cardiovascular outcomes research; 
therefore, we selected a research impact definition that 
was considered contextually applicable, defined as “the 
demonstrable effect from basic, health systems, patient 
and population-oriented research, and clinical trials that 
Keywords: Research impact, Impact matrix, Research output, Implementation science, Cardiovascular outcomes, 
Evaluation, Health research, Research translation, Knowledge translation, Dissemination
Fig. 1 Linear research impact pathways (Source: Fryirs et al. [12], modified from Morgan et al. [15]. Use of this image is supported by the Creative 
Commons Attribution Non-Commercial (CC BY-NC 4.0) license. See: http:// creat iveco mmons. org/ licen ses/ by- nc/4. 0/)
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ultimately improve healthcare delivery, human health 
and quality of life, and generate benefits for the economy, 
society, culture, public policy or the environment.” [10, 
16]. The importance of measuring this impact is clear. 
Large amounts of public funding are directed towards 
health research, so it is important that recipients of those 
funds show accountability and demonstrate relevance to 
the needs of clinicians, patients, and the health systems 
within which they operate [17]. Furthermore, the alloca-
tion of research funding increasingly relies on informa-
tion regarding the impact of previous projects.
A range of approaches to measuring research impact 
have been adopted internationally [18], perhaps most 
prominently the “Payback” method [19]. Payback meas-
ures both academic outputs and wider societal ben-
efits to assess the impact of health research [20]. There 
are two components to the Payback, one is a model that 
studies specific components of research and dissemina-
tion, and the second is a classification scheme for out-
puts, outcomes, and impacts. However, the Payback 
and similar frameworks are generally used to measure 
research benefit at the macro-scale (e.g. nationally) over 
long time periods (often decades) and may be cumber-
some to apply to smaller, time-constrained programmes 
of research or individual projects, where specific funding 
for this additional layer of evaluation may not be avail-
able. More recently, Searles et  al. developed the Frame-
work to Assess the Impact from Translational (FAIT) 
health research, which can be feasibly applied to individ-
ual research projects. This framework incorporates three 
approaches: (1) modifications to the Payback Framework 
to help quantify research impact; (2) an economic meas-
ure of social return on investment; and (3) narrative case 
studies of how the research generated impact, particu-
larly for those that are difficult to quantify [21]. The FAIT 
relies on two assumptions: (1) that research translation 
activity has occurred within the life cycle of the project 
and (2) measurement has been applied prospectively. For 
projects where these assumptions cannot be met, a prag-
matic approach could be considered. Bespoke tools that 
consider a suite of potentially appropriate metrics drawn 
from multiple frameworks may allow more consideration 
of the complex, contextually dependent nature of trans-
lating research into impact.
Cardiovascular research provides a good case study for 
the evaluation of impact, due to the large volume of allo-
cated funding and academic outputs produced. Broadly, 
the long-term return from cardiovascular research has 
seen substantial improvements in survival of people 
affected by cardiovascular disease [22]. Whether new 
research findings can continue the success in translat-
ing findings into improved health outcomes remains an 
open question. To date, there is a paucity of information 
documenting the wider impact of specific cardiovascu-
lar research projects. Here, we explore the application 
of a research impact matrix to assess the impact of car-
diovascular outcomes improvement research, including 
both “hard” impacts that can be directly attributed and 
“soft” impacts indirectly attributed to an Australian col-
laborative research centre. We present a programme 
impact evaluation case study for the first four years of a 
Centre of Research Excellence in Cardiovascular Out-
comes Improvement (2016–2020) initiative, funded for 
AUD$  2,583,231 by the Australian National Health and 
Medical Research Council. The Centre of Research Excel-
lence funding scheme provides support for teams of 
researchers to pursue collaborative research and develop 
capacity in clinical, health services, public health, and 
dementia research. The objective of the scheme is to 
improve health outcomes and promote or improve trans-
lation of research outcomes into policy and practice, in 
addition to supporting researchers in capacity-building 
activities [23].
We document the feasibility, lessons learned, and chal-
lenges encountered when applying a research impact 
matrix to explore how research output from this centre 
has influenced healthcare policy and practice. The pri-
mary aim of this paper was to explore the application of a 
research impact matrix to assess the impact of cardiovas-
cular outcomes improvement research.
Methods
Case study context
The process of applying a framework to assess the impact 
of cardiovascular outcomes improvement research is 
explored through a nationally funded research centre. 
This centre involved a collaborative team of 10 investi-
gators from multiple academic institutions and health 
service organizations across Australia. The consortium 
of research-focused clinicians, academics, consumers, 
and other stakeholders fostered development of national 
capability in cardiovascular comparative effectiveness 
and quality of outcomes research, by utilizing established 
and developing the footprint of cardiovascular registries. 
A key aim of the centre was to develop a national plat-
form for encouraging and facilitating excellence in car-
diovascular trials, achieved through the establishment of 
the Australian and New Zealand Alliance for Cardiovas-
cular Trials network. Themes of research for the centre 
were risk factors, acute cardiovascular disease, coronary 
artery revascularization procedures (cardiac percutane-
ous coronary intervention and cardiac surgery), and the 
management of heart failure. Details of the seed projects 
and scholarships directly funded by the centre are pro-
vided in Additional file 1.
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Selecting a research impact framework
There is currently little consensus on the most appro-
priate tool to measure research impact. We conducted 
a literature review to identify a health-focused research 
impact framework that would meet the specific needs of 
the key stakeholders, primarily (1) without a requirement 
for prospectively applied measures and (2) a simple and 
feasible approach to include different health impact cate-
gories and metrics within a single tool. However, we were 
unable to identify a unique research impact assessment 
framework meeting the full set of requirements.
Instead, we took a pragmatic approach and considered 
the application of a research impact matrix developed 
by Rivera et  al. [24]. This research impact matrix was 
developed from a systematic review of existing meth-
odological frameworks used to measure research impact, 
summarizing common themes and metrics. It allows the 
selection of components from existing methodological 
frameworks, generating a bespoke tool to understand 
and maximize various impact pathways over different 
time frames. Rivera et al. identified five major impact cat-
egories, 16 impact subgroups, and 80 different metrics 
across 24 existing methodological frameworks [24]. The 
five impact categories are (1) primary research-related 
impact, (2) influence on policy-making, (3) health and 
health systems impact, (4) health-related and societal 
impact, and (5) broader economic impact. Researchers 
do not necessarily need to address every aspect of the 
methodological framework, as every project is expected 
to impact the categories and subgroups differently. The 
original authors suggest a multidimensional approach 
that adopts narratives, quantitative metrics, and elements 
from other frameworks, arguably representing a novel 
and more comprehensive method of impact assessment 
than reliance on a single tool.
Choosing the measurement approach and metrics
Impact does not occur at single time points. It can be 
sporadic or sustained. Rarely will linear pathways ade-
quately capture the complex and contested nature of this 
process. Therefore, we must acknowledge both the limi-
tation of categorizing certain types of impact based on 
time frames as well as the pragmatic necessity of doing 
so. How we represent and measure the impact of cardio-
vascular outcomes research according to short-, mid- and 
long-term timelines poses a particular challenge, as in 
some instances research has taken 25–50 years to deliver 
impact [25–27]. Impactful research can lead to paradigm 
shifts that reshape the field and context of application, 
framing further phases of research, policy and practice. 
Capturing the entirety of these processes can be chal-
lenging, if not impossible.
In light of these challenges, we have outlined how we 
allocated each measurement and metric to the research 
impact matrix categories. We did not take a deductive 
approach of pre-specifying metrics; rather an iterative 
stance was taken to ensure metrics were contextually 
relevant to the specific cardiovascular health research 
undertaken. In the early stages of identifying potentially 
relevant metrics and measurements of impact, it became 
clear that mapping and attributing impacts across various 
programmes of research within an umbrella consortium 
would be particularly difficult. There were a wide range 
of both direct and indirect impacts, and uncoupling the 
centre’s activities from those of its component members 
or determining the counterfactual of impact that would 
have occurred without the existence of the centre pre-
sented unique challenges. To address these challenges, 
we attempted to articulate what we considered both 
“direct” and “indirect” impacts, which were aligned to 
the notion of “soft” and “hard” impacts used in the River 
Styles Framework, which is another research impact 
framework used in the environment sciences [12].
Research‑related impact
Academic measurements capturing metrics such as 
knowledge generation, dissemination, and the develop-
ment of capacity and networks were considered short-
term impacts, as the first evidence of return on research 
investment. Direct research-related impacts were those 
metrics (e.g. publications) arising from projects funded 
by the centre’s grants and scholarships. Indirect impacts 
were metrics associated with the centre, for example, 
supporting the establishment of a clinical trial network, 
which was a joint effort of cardiovascular researchers 
both internal and external to the centre.
Influence on policy‑making
Metrics that captured the interaction between academ-
ics and policy-makers to develop and implement pol-
icy were considered mid-term impacts (approximately 
1–3 years). These outcomes represented interim impacts 
that are reliant upon building an evidence base and pro-
vide a pathway to translating the benefits of this evidence 
into practice. Direct influence on policy-making impacts 
was articulated as metrics with clear attributable links to 
centre-funded activity, such as publications from centre-
funded projects being cited in clinical practice guide-
lines or centre-funded PhD candidates transitioning to 
industry, clinical, or academic roles. Indirect impacts 
were framed as the involvement of centre investigators in 
policy-making (e.g. contributing to the development of a 
national cardiovascular registry).
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Health and health systems impact, health‑related 
and societal impact, and broader economic impact
These impacts represented a time frame beyond five 
years according to the research impact matrix, requir-
ing a mix of ex-post and ex-ante reporting, as the cen-
tre had only been running for four years at the time of 
research impact evaluation. However, some of the impact 
subgroups had been captured within the four-year time 
frame.
Process
The research impact assessment was conducted in two 
stages, as described below.
Stage 1: Involved preliminary mapping of the centre 
impacts according to the matrix of impact categories and 
subgroups. Review of existing internal centre documen-
tation and publicly available information sources (e.g. 
Google Scholar) was used to allocate known impacts 
according to short-, mid- and long-term timelines. Stage 
1 was conducted by an independent researcher (MS) who 
was not involved in any of the projects or running of the 
centre. The initial research impact matrix was then sent 
to the centre investigators for their review and amend-
ments, completing the first draft.
Stage 2: Informal semi-structured telephone discus-
sions were then conducted between April and June 2019 
by the independent researcher (MS) with each of the 
centre investigators for every project, grant, and scholar-
ship. These telephone discussions were used to identify 
the relevant impacts achieved and which impact category 
and subgroup they best aligned with (approximately 
20–60  min). The conversation was structured using the 
research impact matrix developed by Rivera et  al. [24], 
and questions were asked about each of the impact cate-
gories and subgroups. Further prompts were provided for 
specific example metrics when the centre investigators 
were uncertain of how to interpret the impact categories 
and subgroups. Notes were taken by the independent 
researcher throughout the discussion, which were used 
to summarize the research impact matrix results for the 
centre’s projects. Iterative discussions were decided as the 
best way to elicit different forms of impact, as it allowed 
the investigators to explore their projects and clarify 
whether certain measures and metrics could be consid-
ered “impact”. This predominantly synchronous exchange 
was considered a more appropriate approach, as asyn-
chronous communication over email or via a survey was 
thought to potentially risk constraining the process and 
lead to missing key impacts. Most of the investigators 
were located in different states or internationally at the 
time of the evaluation. One of the investigators could not 
be interviewed, as they passed away shortly after the cen-
tre’s commencement. Upon completion of the telephone 
discussions with each investigator, additional impacts 
were sought by emailing the completed impact matrix 
to each of the centre’s grant and scholarship recipients 
to confirm the information obtained and add anything 
missed during the discussions with centre investiga-
tors. These grant and scholarship recipients were mostly 
early career researchers who were able to provide addi-
tional contextual information regarding the projects and 
research impact. A manual search of academic outputs 
was then performed to obtain citations and impact fac-
tors for the identified publications.
Results
Case study: Centre for Research Excellence 
in Cardiovascular Outcomes Improvement
Over the first four years of the research centre, there 
were 13 seed grant projects, seven scholarships, and 
three investigator-led projects. Seed grant projects typi-
cally funded early career researcher-led investigations 
under the supervision of one or more of the centre’s 
investigators. The scholarships were directed towards 
PhD candidates who were considered to have high poten-
tial to attract additional sources of funding for their 
work. Three investigator-led projects encompassed larger 
initiatives, which were part of broader efforts outside the 
centre. Scholarship recipients were expected to obtain 
further funding from national and other sources to free 
up scholarship funding for more researchers, which was 
achieved throughout the life of the centre. The research 
impact matrix results for the centre’s projects are pre-
sented in Table 1.
The centre covered short-term impacts across research 
and innovation outcomes, dissemination and knowledge 
transfer, academic collaborations, research networks, 
and data sharing. The use of prompts by the independ-
ent researcher elicited previously unreported impact 
metrics, allowing quantitative measurement. Mid-term 
impacts were captured under one category of influencing 
and involvement in policy-making, with three subgroups: 
level of policy-making, type and nature of policy impact, 
and policy networks. While these impacts were known 
to the investigators, they had not been explicitly meas-
ured as research impacts elsewhere. Descriptions of these 
impacts were difficult to quantify, such as contributions 
to establishment of registries, guideline development, 
and Medicare Benefits Scheme reimbursement item 
number applications. Long-term impacts were reported 
under three categories, across nine subgroups. Impact for 
some subgroups were unable to be identified due to the 
formative nature and preliminary timing of this impact 
evaluation. A mix of descriptive and quantitative meas-
urements were reported for evidence of change in clinical 
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Table 1 The research impact matrix for the Centre for Research Excellence in Cardiovascular Outcomes Improvement projects
Time frame Impact categories Impact subgroups Outputs/outcomes
Short-term 1. Research-related impact Research and innovation outcomes Direct
Peer-reviewed publications (n = 41)
Number of citations (n = 87)
Journal impact factor (median 2.843; range 1.248 
to 23.239)
Manuscripts under review or development (n = 26)
Indirect
Associated publications (n = 156)
Dissemination and knowledge transfer Direct
Conference presentations (n = 61)
Total PhD candidacies commenced (n = 7):
  PhD candidacies with cross-institutional collabora-
tion (n = 1)
Academic collaborations, research networks and 
data sharing
Direct
Total new academic collaborations (n = 5):
  International collaborations (n = 3)
New database linkages (n = 6):
  Admitted episodes & emergency episode
  National Death Index
  Ambulance Victoria
  Australian and New Zealand Society of Cardiac and 
Thoracic Surgeons National database
  Combined Australian acute coronary syndrome 
registries (n = 16,500)
  Development of a multistate linked data platform 
for analysis of coronary heart disease in younger 
adults
Indirect
Utilization and reinforcement of a national general 
practice network to conduct research (> 2000 
members)
Establishment of the Australian and New Zealand 
Alliance for Cardiovascular Trials network (> 200 
members)
Mid-term 2. Influencing and involvement in policy-making Level of policy-making Indirect
Centre contribution to the development of a 
national cardiac data registry
Centre contribution to the development of the 
National Heart Foundation guidelines [35-37]
Type and nature of policy impact Direct
Contribution to Medicare Benefits Schedule reim-
bursement item number application:
  Ambulatory blood pressure monitoring
Implementation of patient reported outcome 
measures in several data registries:
  Coronary Angiogram Database of South Australia
Victorian Cardiac Outcomes Registry
Policy networks Direct
Establishment of new industry collaborations (n = 9)
Embedded academic and statistician roles in 
industry
  Western Australian Department of Health
PhD candidate transition to industry role (n = 1)
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practice, patient outcomes, consumer involvement, and 
further research funding.
Feasibility of the research impact matrix
We considered the research impact matrix a feasible 
tool to identify evidence of academic and policy impact 
across short- and mid-term timeframes, otherwise not 
Table 1 (continued)
Time frame Impact categories Impact subgroups Outputs/outcomes
Long-term 3. Health and health systems impact Evidence-based practice Direct
Establishment of longitudinal data capture regard-
ing change in practice:
  Coronary Angiogram Database of South Australia 
[38]
  Percutaneous coronary intervention [39]
  Door-to-balloon time [40]
  Coronary artery bypass graft surgery [41]
Development of contemporary management for 
aortic stenosis [42, 43]
Development of a risk prediction model linked with 
cardiovascular data registries, which is reportedly 
used ongoing and has directly impacted hospital 
care [44, 45]
Quality of care and service delivery Direct
Validation and auditing of registry data so it can 
be used to improve quality of care and service 
delivery:
  Coronary Angiogram Database of South Australia
  Melbourne Interventional Group database [46]
  Australasian Society of Cardiac and Thoracic 
Surgeons database [46]
Prevention targets developed from the identifica-
tion of risk factor burden, clinical profile, and 
morbidity patterns of adults < 55 years with acute 
coronary syndrome
Cost containment and effectiveness Direct
Cost-effectiveness of surgery vs stenting estab-
lished:
  Percutaneous coronary intervention vs surgery 
for the treatment of multivessel coronary artery 
disease in the drug-eluting stent era [47]
  Coronary artery bypass surgery vs stenting in high-
risk patients [48]
  Guideline-driven use of drug-eluting stents [49]
Resource allocation No information identified
Health workforce No information identified
4. Health-related and societal impacts Health literacy No information identified
Health knowledge, attitudes and behaviours No information identified
Improved social equity, inclusion or cohesion No information identified
5. Broader economic impacts Economic impacts Direct
PhD candidates transitioned from centre-funded 
to externally funded scholarship (n = 6; 
AUD$300,586)
Centre grant recipients awarded additional external 
research funding:
  National Health and Medical Research Council 
(total AUD$2,481,816)
  Medical Research Future Fund (total 
AUD$2,062,697)
Leveraged industry grants (n = 2):
 Emergency Medicine Research Foundation 
(AUD$150,000)
National Heart Foundation Vanguard Grant 
(AUD$73,000)
The term industry refers to all non-academic organizations, including governmental, non-governmental, and private
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documented through traditional research criterion and 
project evaluations. We did not identify any types of 
impact that could not be categorized into the research 
impact matrix domains. For the centre’s projects, the 
matrix assisted the investigators in contemplating out-
puts across the range of categories and subgroups that 
otherwise would have gone undocumented. Support and 
prompting from the independent researcher were crucial 
to the identification of these outputs and impact, as well 
as describing and quantifying metrics for each domain. 
Given the importance of this synchronous exchange, we 
remain convinced that relying on the centre documenta-
tion and publicly available information alone would not 
have been sufficient to capture the full range of impacts. 
Further, an asynchronous approach using survey or email 
exchange would likely not have resulted in the same 
depth of exploration with the centre’s investigators. Most 
of the reported research impact was captured under the 
short-term research domain category, such as scientific 
journal publications, citations of published work, dis-
semination of information and knowledge transfer (e.g. 
conference presentations), and academic collaboration 
activity. The most challenging areas of impact to meas-
ure were related to long-term health and health sys-
tems, health-related and societal, and broader economic 
outcomes.
Challenges encountered when applying the research 
impact matrix
The impact categories considered within the long-term 
time frame were the most challenging aspects to measure 
and report. Measuring health and health system impact 
through changes in evidence-based practice would 
require fundamentally different study designs to those 
typically employed in clinical research projects. Most of 
the funded work within the centre was engaged in effec-
tiveness research, focused on translating the benefits of 
therapies from efficacy trials to real-world settings. How-
ever, an entirely different set of study designs is required 
to enable changes in evidence-based practice, namely 
encompassed within the field of implementation science. 
Implementation studies are positioned at the end of the 
research translation pipeline, and typically require the 
evidence base for an intervention, programme, or policy 
to be established prior to exploring how it may be imple-
mented into practice [28, 29]. The time frames for this 
process are typically beyond what would be considered 
feasible for an ex post research impact evaluation of this 
nature, given it reportedly takes, on average, approxi-
mately 17  years for only 14% of research into practice 
[30].
Changes in health-related societal impacts were also 
difficult to measure given the first four-year time frame 
of the centre’s work. Capturing broader societal changes 
in health literacy, knowledge, attitudes, and behaviours 
proved beyond much of the data captured by clinical 
research translation activities. The paucity of available 
data in these areas of research impact indicates that pro-
spective planning and data collection may be warranted 
for other projects wishing to capture these categories of 
research impact.
Cost containment and broader economic impacts rep-
resented another difficult area of impact to measure. The 
data needed to model economic returns was not always 
adequately captured. Further, input from a health econo-
mist, while available for our work, is not always resourced 
in project teams.
Discussion
Lessons learned from the application of a research impact 
matrix
In applying a research impact matrix for a case study in 
cardiovascular outcomes improvement it became clear 
that there is no one tool (or set of tools) that can cover 
the diversity of circumstances in health research. The 
complexity of capturing all relevant measures of impact 
not only presented itself when trying to choose a frame-
work, but became more apparent when identifying and 
capturing potential metrics as well as categorizing these 
according to timeframes and domains of impact. On 
reflection, it was important to tailor the choice of frame-
work and measures of impact iteratively throughout the 
process, particularly given the cyclical nature of inputs, 
activities, outputs, and outcomes in research which is 
striving to generate new knowledge.
An important lesson to arise from our application of 
a research impact framework is the predominantly con-
text-dependent nature of research impact [16, 31]. The 
presented case study is situated in a mixed public and 
private funded health system from a high-income coun-
try, where impact is typically conceptualized as a direct 
and linear process from quantitative findings to relatively 
short-term changes one step removed from patient out-
comes [18]. Our case study unsurprisingly favoured a 
similar narrative, focusing on potentially high economic 
returns without in-depth exploration of the interactions 
by which indirect impacts might occur. Methods that 
incorporate co-design principles, participatory designs, 
and rigorous qualitative approaches might have allowed 
us to capture the nature and mechanisms of research 
impact, potentially creating a more complete under-
standing of this multidimensional process within com-
plex health systems.
Another important learning from this work pertains to 
the respective value and benefit of a formative or sum-
mative approach to research impact. We took a formative 
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approach exploring the research impact on cardiovascu-
lar outcomes improvement ex-post from the first four 
years of the collaborative centre. This was done to ensure 
that findings could be used by the investigators to inform 
ongoing decisions regarding the investment of research 
funding towards implementation and translation activi-
ties, before the end of the funding period. Four years is 
a relatively short time period in cardiovascular outcomes 
research [16]. However, anecdotal feedback from the cen-
tre’s investigators indicated that exploring their research 
impact formatively encouraged prospective investment 
of resources in research translation projects and activi-
ties. The centre investigators often articulated how their 
research might achieve impact ex-ante, through the 
discussions when applying the research impact matrix 
to their projects. The formative application of impact 
frameworks to encourage research translation has been 
proposed by Ramanathan et al., which provides the addi-
tional benefit of facilitating collection of process, output, 
and interim outcomes related to research impact [10].
Suggestions for future research impact assessment 
in cardiovascular outcomes research
In the presented case study, we applied the research 
impact matrix retrospectively to the first four years 
of the collaborative centre, identifying mostly the ex-
post impacts of the centre. We propose that a prospec-
tive approach from the beginning of the funding period 
(including prospective data collection) may have yielded 
more insightful findings, as relevant measurements could 
have been preplanned to capture the expected research 
impacts over the lifetime of the funded centre. We were 
unable to capture many important metrics or the requi-
site data to conduct an economic impact evaluation. Fur-
ther, articulating ex-ante pathways for research impact 
at the beginning of the case study projects may have 
promoted additional translation- and implementation-
focused designs to be incorporated with the studies on 
the effectiveness of different treatment modalities for 
cardiovascular outcomes improvement. Future evalu-
ations of the impact of research may provide a more 
accurate, nuanced, and useful evaluation if prospective 
planning can take place prior to awarding of research 
funding. If appropriate measures can be identified and 
collected for both formative and summative evaluation, 
research activity may be able to be more targeted towards 
translation and impact, particularly at the later periods of 
funded projects. Research funding agencies may be well 
served by requiring reporting of the impact and transla-
tion of funded research projects to ensure future award-
ing decisions are made to groups with a track record of 
translating and implementing research into practice [32].
Strengths and limitations
One of the main strengths of this study was the prag-
matic approach to apply a research impact matrix that 
summarized common themes and metrics used across 
several existing methodological frameworks. This 
approach had two main benefits; firstly, it allowed the 
sufficient tailoring to the context of application where 
specific measures of impact were not collected prospec-
tively, and secondly, provided a simple, contemporane-
ous, and resource-efficient process to identify different 
impact categories across the programme of research. The 
time and cost involved in applying many research impact 
assessment frameworks is an important consideration for 
research teams and funding agencies, given the potential 
opportunity costs associated with their implementation. 
Opportunity costs occur because resources spent on 
conducting a research impact assessment are the same 
resources that can no longer be used to conduct other-
wise valuable research [33]. Therefore, it is important to 
ensure the benefits of research impact assessment out-
weigh the costs of engaging in this activity [34]. Given 
the pragmatic nature of our approach, it was important 
to ensure robustness and trustworthiness. Multiple data 
sources, including documentation review, bibliometric 
searches, and discussions with the centre investigators, 
were used to triangulate information ideally ensuring 
multiple accounts pointed to the same result. An inde-
pendent researcher collated the information and engaged 
in the discussions with centre investigators, providing a 
validating check to ensure suggested outputs and impact 
were objective, administratively efficient to apply metrics, 
transparent, and comparable. Further, claims made by the 
centre investigators were confirmed with scholarship and 
grant recipients as an additional source of validation.
There were limitations to conducting the research 
impact evaluation before the completion of the cen-
tre’s funding term. The impact of research usually takes 
a long time to occur, often well beyond the completion 
and dissemination of the findings. The relatively short 
time frame of four years since research programme com-
mencement meant that it was difficult to capture meas-
ures of impact beyond short-term academic outputs and 
mid-term influence on health policy. Reliance on ret-
rospective, self-reported recall from investigators also 
limited the ability to apply quantitative measures and 
metrics for several of the reported impacts. This limita-
tion resulted in the reliance on descriptions, which are 
difficult to verify. Further, a more robust qualitative 
approach could have been used to obtain more trustwor-
thy responses during the semi-structured discussions 
with centre investigators. Some research impact evalu-
ations include an exploration of the economic benefits 
of the research conducted, but this was not completed 
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as part of our evaluation due to its formative nature 
and limited prospectively collected data regarding cost-
effectiveness. Our limited exploration of the activities 
and pathways to research impact constrained the abil-
ity to trace a linear logic from “the bench to bedside”. 
This was perhaps a result of the research impact matrix 
selected and focus of the relevant stakeholders’ needs. 
Arguably, a more in-depth exploration of the pathways to 
impact may have elucidated where to best direct research 
translation investment, but this was beyond the scope of 
our project. While some efforts were taken to verify the 
claimed impacts from the centre’s research, much of the 
data collection was reliant on self-reported measures. 
This reliance brought about a tension between attribu-
tion and contribution, making it difficult to attribute cer-
tain impacts to particular studies, especially when much 
of the centre’s work was incremental and collaborative. 
However, unlike the scientific approach which aims to 
produce valid, reliable, and generalizable findings, the 
exploration of research impact seeks to understand how 
research has led to impact from the perspectives of spe-
cific stakeholders [34].
Conclusion
The application of a bespoke research impact matrix 
uncovered the impacts of cardiovascular outcomes 
improvement research across and range of domains and 
timeframes. We did not identify any types of impact that 
could not be categorized into the research impact matrix 
domains. Using both synchronous and asynchronous 
means of capturing data from multiple sources required 
support and prompting from the independent researcher 
but led to identification of impact that had not otherwise 
been captured via traditional criterion and evaluations. 
We considered the research impact matrix a feasible tool 
to identify evidence of academic and policy impact in 
the short- to mid-term; however, we experienced chal-
lenges in capturing long-term impacts of cardiovascular 
outcomes improvement research. Cost containment and 
broader economic impacts represented another difficult 
area of impact to measure.
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